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Abstract
Autophagy is an evolutionarily conserved process in eukaryotes by which cytoplas‐
mic cargo sequestered inside double‐membrane vesicles is delivered to the lysosome
for degradation. In early pregnancy, trophoblasts and the fetus experience hypoxic
and low‐nutrient conditions; nevertheless, extravillous trophoblasts (EVTs) invade the
uterine myometrium up to one‐third of its depth and migrate along the lumina of
spiral  arterioles,  replacing  the  maternal  endothelial  lining.  An  enhancement  of
autophagy induced by physiological hypoxia takes part in the invasion and vascular
remodeling in EVTs. On the other hand, soluble endoglin, which increased in sera in
preeclamptic cases,  suppresses EVT‐invasion or ‐vascular remodeling by inhibiting
autophagy In vitro. In addition, a substance selectively degraded by autophagy, p62/
SQSTM1, accumulates in EVT cells in preeclamptic placental biopsy samples showing
impaired  autophagy  in  vivo.  Thus,  alternation  of  autophagy  could  affect  fates  of
mothers  and  babies.  Recently  increasing  evidence  of  modulating  autophagy  has
accumulated during pregnancy. In this chapter, we introduce the role of autophagy
in embryogenesis, implantation, and maintaining pregnancy.
Keywords: autophagy, extravillous trophoblast, hypoxia, invasion, preeclampsia, p62/
SQSTM1, soluble endoglin
1. Introduction
The placenta acts to mediate the exchange of materials between mother and fetus under
hypoxic and low‐nutrient conditions during the early gestation period [1, 2].  It has been
reported that hypoxia and low nutrient, which are generally harmful for cells, are preferable
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for trophoblasts during the early gestation period [3–5], indicating that trophoblasts possess
evolutionary mechanisms allowing them to adjust to stress. In other words, disruption of these
adaptive mechanisms may contribute to placental dysfunction, which induces preeclampsia
and fetal growth restriction (FGR). Preeclampsia is one of the important diseases for life
threatening a baby as well as a mother. It  also causes FGR. Ten million women develop
preeclampsia each year, and 76,000 mothers among them die each year all over the world. A
recent interest for autophagy researchers is how autophagy contributes to the human diseases.
It is getting clarified the role of autophagy for pathophysiology of preeclampsia or pregnancy‐
related diseases. In this chapter, we focus on the role of autophagy as a cellular cytoprotective
mechanism, especially for embryogenesis, implantation, and maintaining pregnancy.
2. Autophagy in embryogenesis and implantation
Macroautophagy (herein referred to as autophagy) has long been considered a nonselective
process for bulk degradation of either long‐lived proteins, or cytoplasmic components during
nutrient deprivation. Autophagy works for not only cellular energy metabolism, but also
quality control for cellular protein (by eliminating protein aggregates, damaged organelles,
lipid droplets, and intracellular pathogens) [6]. Though lysosomal degradation is served as a
final step of autophagic machinery, this machinery can be deployed in some cellular processes:
phagocytosis, exocytosis, secretion, antigen presentation, and regulation of inflammatory
signaling [7]. Consequently, the autophagy pathway is mediated with human diseases, such
as protection against aging, suppression or development of cancers, infections, neurodege‐
nerative disorders, metabolic diseases, inflammatory diseases, and muscle diseases [8–12].
Autophagy has a variety of functions during embryogenesis (Figure 1). Autophagy is highly
induced in fertilized oocytes, but not unfertilized oocytes, within 4 hours after fertilization [13].
As oocytes lacking Atg5 are fertilized normally in vivo, autophagy is not important for
folliculogenesis and oogenesis. Similarly, ovulation, fertilization, implantation, and ovary size
are not affected by the ablation of Beclin1 (BECN1) in luteal cells of ovary [14]. During oocyte‐
to‐embryo transition, many of maternal proteins stored in oocytes are provided to zygotes
(fertilized embryos), the stock of these proteins is largely degraded, and newly synthesized
proteins encoded by the zygotic genome are translated. In mice, it is known that zygotic
transcripts are detected at the late one‐cell stage, and most of the maternal RNAs are eliminated
by the two‐cell stage [15–17]. During this period, autophagy is transiently suppressed from
the late one‐cell to middle two‐cell stages, and reactivated after the late two‐cell stage,
suggesting that autophagy is involved in the degradation of maternal proteins in oocytes. In
addition, complete autophagy‐deficient embryos, which are derived from oocytes lacking Atg5
fertilized with Atg5‐null sperm, arrest at four‐ to eight‐cell stages, but not embryos derived
from oocytes with Atg5‐plus sperm [13]. Protein synthesis rates are reduced in complete
autophagy‐deficient embryos, suggesting that the degradation of maternal factors by autoph‐
agy is essential for preimplantation embryo development in mammals.
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Figure 1. The role of autophagy during embryogenesis: Activation of autophagy occurs from the late two‐cell stage to
the eight‐cell stage. Autophagy helps survival of blastocysts treated with estradiol (E2). Subsequently, EVTs’ invasion,
which is necessary for normal placentation, is supported by hypoxia‐activated autophagy.
A mouse model of experimentally delayed implantation, established by ovariectomy before
blastocyst implantation, showed that Atg7 and LC3 expression is upregulated in blastocysts
made dormant by the elimination of 17β‐estradiol (E2), in comparison with E2‐activated
blastocysts, suggesting that autophagy is sustained during the prolonged survival of dormant
blastocysts [18]. Activation of autophagy is also observed in the inner cell mass, known as the
embryoblast or pluriblast, which will evolutionally give rise to the definitive structures of the
fetus. On the other hand, E2 or progesterone activates autophagy simultaneously with a
decrease in activation/phosphorylation of mTOR (mammalian target of rapamycin) in bovine
mammary epithelial cells [19].
Mice lacking BECN1, which is necessary for autophagy [20], died for early embryonic period
(E7.5 or earlier) with defects in proamniotic canal closure [21]. Ablation of FIP200 (focal
adhesion kinase family interacting protein of 200 kD) in mice also leads to embryonic lethality
at mid/late gestation, which is caused by defective heart and liver development [22]. Most
mouse embryos with functional deficiency of Ambra1 (activating molecule in beclin1‐
regulated autophagy) exhibit neural tube defects in midbrain/hindbrain exencephaly and/or
spina bifida during E10–E14.5 [23]. Therefore, these types of autophagy deficiency are mainly
involved in the impairment of embryonal development. However, it is unknown whether
autophagy deficiency affects placental development or physiological status in dams.
Mice lacking Atg5 are born normally, but die within the first day after birth [24]. Atg7, which
is essential for Atg5‐Atg12 conjugation, knockout mice are also born at expected ratios, with
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large healthy major organs. Similar to Atg5 knockout mice, Atg7 knockout mice also die earlier
than wild‐type controls under nonsuckling conditions after cesarean delivery, and have lower
plasma amino acid levels [25]. Atg3, Atg9, and Atg16L1 conventional knockout mice demon‐
strate similar phenotypes [26–28]. The exact reason for neonatal death in those knockout mice
is still controversial, and observation of a suckling defect may indicate a neuronal defect.
However, the above studies demonstrate that amino acid supply through autophagy is
important for mouse neonatal survival, preventing sudden starvation at birth. In addition,
autophagy knockout mice that are born normally exhibit slightly inhibited fetal growth. It is
still unknown whether inhibited growth is a result of defects within the placenta, or by
mechanisms within the pups themselves. This question could be elucidated with the use of
placenta‐specific autophagy‐deficient mouse. The BECN1‐containing PI(3)K and ULK1‐FIP200
complexes function early in the autophagy process at the autophagosome nucleation step [9,
29], while Atg3, Atg5, Atg7, and Atg16L1 function later at autophagosome elongation. As
shown in Table 1, genetic knockout upstream factors may produce more severe phenotypes,
or alternatively, as recently reported, downstream factors may be responsible for a particular
type of macroautophagy [30]. In fact, LC3B knockout pups survive longer than their wild‐type
counterparts without a compensatory increase in LC3A, demonstrating opposite results to the
other Atg‐knockout mice [31]. Atg4C, a family of cysteine proteinases for processing and
delipidation of Atg8, knockout mice also indicate that Atg4C is dispensable for embryonic and




Neonatal lethal with reduced amino acid levels, suckling defect
(Atg5: the failure of the four‐ and eight‐cell stages in embryogenesis)
Beclin 1−/− Early embryonic lethal (E7.5 or earlier) with defects in proamniotic canal closure
(heterozygous mice show increased susceptibility to spontaneous tumor)
FIP200−/− Embryonic lethal (E13.5–E16.5) dueto defective heart and liver development
Ambralgt/gt Embryonic lethal (‐E14) with defects in neural tube development, and
hyperproliferation of neural tissues
ULK1−/− Increased reticulocyte number with delayed mitochondrial clearance
Atg4C−/− Viable, fertile, increased susceptibility to carcinogen‐induced fibrosarcoma
LC3B−/− Normal phenotype, production higher levels of IL‐1β and IL‐18 in response to LPS
GABARAP−/− Normal phenotype
Table 1. Phenotypes of systemic knockout mice of Atg‐related genes.
3. The role of autophagy in trophoblasts for normal development of the
placenta
In humans, trophoblast stem cells differentiate into two cell types: villous trophoblasts and
extravillous trophoblasts (EVTs). Invading trophoblasts called interstitial EVTs migrate into
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the decidualized endometrium, and endovascular EVTs migrate along the lumina of spiral
arterioles. The invasion of spiral arteries by EVTs starts early in pregnancy, and the endovas‐
cular trophoblastic cells aggregate in the lumen of the vessel forming the “trophoblastic plug”
to allow the growth of the embryo and the placenta in a low‐oxygen environment (Figure 2).
As the EVTs migrate away from the villi and invade the maternal decidua, they progressively
develop an invasive phenotype without proliferation [33], and stop at one‐third of the depth
of the myometrium in the uterus. EVTs invade the maternal decidua under harsh conditions,
including low oxygen (2–5% O2) and low‐glucose concentrations (1 mM), until 11 weeks of
gestation [33, 34]. During the invasion, the hypoxia inducible factor (HIF) system plays a critical
role in their functions. After 12 weeks of gestation, endovascular EVTs invade the uterine spiral
arteries, replace their endothelial cells, and participate in the degradation of tunica media
smooth muscle cells under moderate hypoxia (approximately 8%). This remodeling of the
spiral arteries is essential to allow a proper placental perfusion to sustain fetal growth
(Figure 2). In other words, impairment of trophoblast invasion or remodeling may contribute
to fetal loss during early pregnancy, or poor placentation during the middle of the pregnancy
period.
Figure 2. Autophagy supports EVT functions under physiological hypoxia: Interstitial EVT invades during 7–11 weeks
of gestation, and vascular remodeling by EVTs occurs during 12–16 weeks of gestation. Cross section‐1 indicates the
“trophoplastic plug” to maintain hypoxia in the conceptus during 7–11 weeks of gestation. Cross section‐2 indicates
separation and apoptosis of vascular smooth muscle cells by endovascular EVTs.
Activation of autophagy is observed in EVTs invading into the maternal decidua at 7 weeks of
gestation, under physiological hypoxic conditions [35]. Hypoxia induces autophagy in
primary trophoblasts [35, 36], and inhibition of autophagy induced by silencing Atg7 in
primary trophoblasts decreases apoptosis under 1% oxygen conditions in the presence of
bafilomycin A1, an inhibitor of lysosome, indicating that autophagy mediates apoptosis in
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trophoblasts under specific conditions. Not only hypoxia, but also starvation induces autoph‐
agy in trophoblasts or some choriocarcinoma cell lines, and LC3‐II/actin levels, a marker of
autophagic activation, vary depending on the cell lines (unpublished data). Though many
independent studies have shown that hypoxia enhances invasion of EVTs, the role of autoph‐
agy in trophoblast functions is still unclear. To elucidate the specific role of autophagy in
trophoblast functions, we constructed autophagy‐suppressed cells by stably transfecting
ATG4BC74A, an inactive mutant of ATG4B, which inhibits autophagic degradation and lipida‐
tion of LC3B paralogs [37]. In these cell lines, the conversion of LC3‐I to LC3‐II was abolished
by starvation, a commonly used autophagy stimulator. Hypoxia enhances the invasive
capacity of EVT cell lines, such as HTR‐8/SVneo, the most widely used EVT cell line, or
HchEpC1b, immortalized by infection with retroviral expression vectors containing the type
16 human papillomaviruses E6 and E7 in combination with a human telomerase reverse
transcriptase, with a normal chromosomal number and no tumorigenic activity [38]. The
invasion was significantly reduced in autophagy‐suppressed EVT cell lines, compared with
autophagy‐normal EVT cell lines, under 2% oxygen tension, which matches the placental
condition until 11 weeks of gestation.
The other function of EVTs, vascular remodeling, is also necessary to precisely develop
placentation. To clarify the role of autophagy in vascular remodeling, tube formation assays
with EVT cells and human umbilical vascular endothelial cells (HUVECs), an in vitro model
of vascular remodeling by EVT cells, were performed under 8% oxygen tension, simulating
physiological levels of oxygen tension after 12 weeks of gestation [39]. Both the autophagy‐
normal EVT cells and the autophagy‐suppressed cells formed a tube structure with HUVECs
at 12 h, but did not form a tube structure in the absence of HUVECs. In the culture with the
autophagy‐normal EVT cells and HUVECs, the tubes were mostly occupied by the autophagy‐
normal EVT cells at 12 h or later; whereas the tubes were not occupied by EVT cells when the
autophagy‐suppressed cells were cocultured with HUVECs, suggesting that replacement of
endothelial cells by EVT cells requires autophagy. Thus, autophagy plays an important role in
the endovascular interaction between EVT and endothelial cells [35].
No difference in HIF1α expression was observed between autophagy‐normal and autophagy‐
suppressed EVT cell lines [35], suggesting that HIF1α is not affected by autophagy status. A
number of studies have investigated the role of the HIF1 pathway in EVT invasion. A decrease
in HIF1α expression induced by siRNA markedly reduced the invasiveness of HTR8/SVneo
cells under hypoxia and normoxia [40]. Hypoxia‐induced autophagy is modulated by the
inactivation of mTOR via AMPK (5′‐AMP‐activated protein kinase) [41]. Additionally, Atg5
knockout, but not wild type, mouse embryo fibroblasts (MEFs) showed no activation of
autophagy under hypoxia [42]. Thus, HIF1α may activate EVT functions, at least partially, by
manipulating autophagy status. Rapamycin or siRNA‐mediated mTOR knockdown, an
activator of autophagy, reduced the invasiveness of HTR8/SVneo cells under normoxia [43].
However, our study revealed no effect of rapamycin on invasion of HTR8/SVneo cells [44].
This result might be explained by a rapamycin‐induced cell cycle arrest in the G1 phase [45].
Hypoxia activates macroautophagy via the HIF1 pathway, and HIF1α seems to be controlled
by autophagy. Chaperone‐mediated autophagy (CMA) has recently shown to degrade
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HIF1α, which is mostly controlled by the oxygen‐dependent proteasome, through LAMP2A,
a lysosomal transporter protein. Interestingly, this new pathway for degradation of HIF1α does
not depend on the presence of oxygen and is activated in response to nutrient deprivation in
rat livers [46]. CMA‐mediated excessive degradation of HIF1α compromises cells’ ability to
respond to and survive under hypoxia, suggesting that the impairment of this pathway might
be of pathophysiological importance in conditions that combine hypoxia with starvation,
including the early pregnancy period, during which EVTs invade.
Placenta expresses LC3B in both cytotrophoblasts and syncytiotrophoblasts. LC3‐II/actin
levels, which indicate activation of autophagy, are higher in placentas from cesarean sections
than from vaginal deliveries [47], suggesting that uterine contraction might inhibit autophagy
in placentas. In other words, autophagy might be activated in normal placenta before delivery.
Autophagic cell death is also reported in amniotic epithelium following the rupture of
membranes in term placentas [48]. Atg9L2 (Atg9b) is specifically expressed in placenta
(trophoblast cells) and pituitary gland, while another homolog Atg9L1 (Atg9a) is ubiquitously
expressed in adult human tissues [49]. Atg9L1 and Atg9L2 are involved in autophagosome
formation [26]. Mouse Atg9L2 is found to be more widely expressed at embryonic stages than
in adulthood. In humans, the expression of Atg9L2 is significantly higher than that of Atg9L1
in human primary cytotrophoblasts, suggesting that Atg9L2 contributes to tissue‐specific and
developmental activation of autophagy. Autophagy‐deficient mice, similar to Atg7 or Atg5
knockout mice, are born at expected ratios, and fetal weight is only slightly lower than that of
wild‐type fetuses. Kojima et al. [50] recently reported the role of autophagy in preeclampsia
in Atg9a−/− mice mated with heterozygous p57Kip2 mice, which develop hypertension and
proteinuria in dams. Fetal death was increased in Atg9a−/− and Atg9a+/− pups, compared with
wild‐type controls [51]. In addition, the body weight of fetuses in Atg9a−/− pups was signifi‐
cantly lower than those of Atg9a+/− or wild‐type pups, suggesting that autophagy sustains fetal
spare ability under stress. A future task is to clarify the role of Atg9b, which is highly expressed
in the placenta.
4. The role of autophagy in the pathophysiology of preeclampsia
The current hypothesis regarding the etiology of preeclampsia is focused on shallow tropho‐
blast invasion and poor placentation [52, 53] (Figure 3). We recently reported that autophagy
was enhanced in EVTs in early gestation placental tissues, which are under physiological
hypoxia [35]. As mentioned previously, the impairment of the invasion and vascular remod‐
eling under hypoxia, which are thought to be a cause of preeclampsia, are observed in
autophagy‐deficient EVT cell lines. Furthermore, soluble endoglin (sENG), levels of which
increase in sera before the onset of preeclampsia, suppresses invasion in EVT cell lines by
inhibiting autophagy. The sENG‐inhibited EVT invasion is recovered by TGF‐β treatment in a
dose‐dependent manner. A low dose of sENG also inhibits the replacement of HUVECs by
EVT cell lines in the in vitro model of vascular remodeling. This is the first report to show the
role of autophagy in poor vascular remodeling during preeclampsia. Several studies have
linked TGF‐β to inhibition of EVT invasion [54–56]. Conversely, one study reported that TGF‐
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β augments EVT invasion [57]. It is well known that sENG binds TGF‐β, thus neutralizing its
effects. Paradoxically, our data showed that TGF‐β neutralized the effect of sENG, resulting in
recovery of HTR‐8/SVneo cell invasion under hypoxic conditions (2% oxygen tension)
mimicking the physiological hypoxia during the early pregnancy period, but TGF‐β showed
no effect on HTR‐8/SVneo cell invasion under 20% oxygen tension. Thus, physiological
hypoxia, in which EVT cells invade into maternal side, was the key to understand the mech‐
anism by which sENG inhibits autophagy in EVT cells. Though TGF‐β has been shown to
induce autophagy accompanied with transcriptional increase of BECN1, Atg5, and Atg7
mRNA in human hepatoma cells, and increases autophagy in mammary carcinoma cells [58,
59], neutralizing effects to sENG by TGF‐β might be more important than autophagy activation
in EVT cells.
Figure 3. Two‐step model of preeclampsia: Poor placentation is happened before 11 weeks of gestation, and endothe‐
lial dysfunction is happened after 12 weeks of gestation. Autophagy might be involved in each step of the pathophysi‐
ology of preeclampsia.
In regard to the role of autophagy in placenta, it remains to be elucidated whether autophagy
is activated or inhibited in preeclamptic placenta. Increased numbers of LC3B dots, a marker
of autophagy activation, in villous trophoblasts were observed in cases of preeclampsia with
IUGR or idiopathic IUGR placentas, compared with normal human pregnancy [60]. Further‐
more, sphingolipids may be involved in autophagic activation in trophoblasts in preeclamptic
placentas [61]. These support the activation of autophagy in villous trophoblasts during
preeclampsia and IUGR. On the other hand, p62/SQSTM1, a protein specifically digested by
autophagy, accumulated in autophagy‐suppressed human cell lines, suggesting inhibition of
autophagy. The expression of p62/SQSTM1 is significantly higher in EVTs in preeclamptic
placentas, demonstrating the inhibition of autophagy in EVTs during preeclampsia. However,
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p62/SQSTM1expression in syncytiotrophoblasts is not observed in either preeclamptic
placentas or normal placentas, indicating the activation of autophagy in syncytiotrophoblasts
[35]. Together, these results suggest that autophagy inhibition occurs specifically in EVTs, and
that there appears to be a difference in autophagic activity between syncytiotrophoblasts and
EVTs in preeclamptic placentas. Sera from preeclamptic patients induce hypertension,
proteinuria, and FGR in pregnant IL‐10−/− mice, indicating that a variety of factors, including
sENG and soluble Flt‐1, contribute to the occurrence of preeclampsia [39]. Additionally,
rapamycin‐induced autophagy in peripheral blood mononuclear cells is suppressed in the
presence of sera from women with preeclampsia, but not women with normotension [62].
Thus, sera from women with preeclampsia modulate the status of autophagy in the placenta.
BECN1 acts as an initiator of autophagy in mammals, and upregulation of BECN1 expression
represses cellular proliferation under hypoxia. The expression of BECN1 mRNA or protein is
significantly higher in IUGR without preeclampsia, than in normal pregnancy [60], and no
significant difference in BECN1 expression is reported between syncytiotrophoblasts of
preeclampsia or normal pregnancy patients [63]. A recent report demonstrated the importance
of BECN1 for maintaining pregnancy in mice. Pregnant dams lacking BECN1 in the ovarian
granulosa cell population showed impaired progesterone production during preterm labor.
Luteal cells in this mouse model exhibit p62 accumulation, which indicates deficiency of
autophagy, and a failure of neutral lipid storage, which is needed for steroidogenesis [14].
Progesterone in humans is produced in syncytiotrophoblasts of the placenta after 8 weeks of
gestation. Despite the difference between mouse and humans, a BECN1 deficiency can be able
to affect preterm birth in humans by different ways. This is the case in the hormonally‐induced
preterm labor model, while inflammation‐induced preterm labor is also enhanced by alterna‐
tion of autophagy flux, resulting in NF‐kB mediated hyperinflammation in the placenta [64].
Finally, an unexpected function of autophagy in the placenta has been revealed: micro RNAs
delivered from human placental trophoblasts to nonplacental recipient cells confer resistance
to infection with different types of viruses, such as human cytomegalovirus, herpes simplex
virus‐1, vaccinia virus, poliovirus, or coxsackievirus B3. This involves exosome‐mediated
transfer of a unique set of placental‐specific effector micro RNAs, indicating that the placenta
is involved in regulating systemic immunity in humans [65].
5. Attention for estimating autophagy
Mizushima et al. [66] stated that there is no single “gold standard” for methods to monitor or
modulate autophagic activity or flux. Rather, one should consider the use of several different
concurrent methods (with nonoverlapping limitations) to accurately assess the status and
functions of autophagic activity in any given biological setting. Of note, a common miscon‐
ception for estimating autophagic activity often occurs in human tissue samples. Increased
numbers of autophagosomes, LC3 dots, in cells does not invariably correspond to increased
cellular autophagic activity. Tissue samples reflect only one time point when they are fixed,
but “autophagy flux” could have occurred before fixation. Thus, autophagosome accumula‐
tion may represent either autophagy induction, or alternatively, suppression of steps in the
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autophagy pathway downstream of autophagosome formation. The blockade of any step
“downstream” of autophagosome formation increases the number of autophagosomes. In
contrast, the blockade of any step “upstream” of autophagosome formation decreases the
numbers of all autophagic structures. Therefore, simply determining the quantity of autopha‐
gosomes is insufficient for an overall estimation of autophagic activity. Indeed, in tissue
samples, the quantities not only of autophagosomes, but also of autolysosomes, are available
for estimating autophagic activity. In addition, we found that p62/SQSTM1, which becomes
incorporated into the completed autophagosome and is degraded in autolysosomes, was
accumulated in some trophoblast cell lines in which autophagy is suppressed by Atg4BC74A
mutant [35]. The accumulation of p62/SQSTM1 could assist in the estimation of the level of
impairment of autophagy in the placenta. Autophagy researchers anticipate that better assays
will be developed to monitor autophagy, and that more specific agents will be developed to
modulate autophagy. Indeed, more advances are necessary to accurately assess the status of
autophagy in human tissues in order to improve clinical therapies involving modulation of
autophagy.
6. Future directions
A growing body of evidence indicates that autophagy plays a key role in placentation and
contributes to differences observed between normal pregnancy, preeclampsia, and IUGR. The
placenta contributes to systemic immunity by activating autophagy in extraplacental cells. We
believe that autophagy affects numerous functions, including protection from stress, energy
regulation, immune regulation, differentiation, proliferation, and cell death in the placenta.
Better molecular characterization of the autophagic pathways, as well as the possibility of
genetically manipulating these cellular processes, will further elucidate the link between
autophagic abnormalities and disease. The first and most important issue is how we determine
the status of autophagy in the placenta. The status of a preeclamptic placenta is affected by
severity, infarction, infection, degree of cell damage, genetic background, immunological
status, and age. As mentioned previously, the elevation of autophagosomes observed in many
disease conditions, initially interpreted as an increase in macroautophagy, is now more
cautiously interpreted, because blockage of further downstream in this pathway can also
produce a similar morphological signature. Thus, conditions initially labeled as having ‘too
much autophagy’ are being currently reinterpreted as having ‘a blockage in autophagic
clearance’. Precise estimation of autophagy status will likely help to elucidate autophagic
mechanisms implicated in placental disorders.
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